Intelligent Digital Twins for Molecular Diagnostics Manufacturing: A Framework for Predictive Maintenance and Quality Assurance

Abstract

Molecular diagnostics manufacturing faces critical challenges including unplanned equipment downtime, contamination risks, and stringent regulatory requirements. While digital twin technology has demonstrated transformative value in aerospace and automotive manufacturing, and healthcare digital twins are revolutionizing patient care, molecular diagnostics manufacturing equipment remains virtually absent from digital twin implementations. This white paper presents the first comprehensive framework for intelligent digital twins specifically designed for molecular diagnostics manufacturing. The framework integrates IoT sensor networks, physics-based modeling, AI-driven predictive analytics, and FDA compliance mechanisms into a three-layer architecture addressing the unique requirements of nucleic acid amplification equipment. Key contributions include: (1) a modular, scalable system architecture combining interpretable mechanistic models with high-accuracy machine learning predictions, (2) detailed specifications for sensor deployment, data acquisition, and edge computing infrastructure, (3) hybrid modeling approaches balancing regulatory explainability with prediction performance, (4) built-in FDA 21 CFR Part 11 compliance and equipment qualification protocols, and (5) practical implementation guidance for practitioners. The framework enables transition from reactive to predictive maintenance, with expected benefits including 30-50% downtime reduction, 20-40% maintenance cost savings, and substantial quality improvements. This work establishes a foundation for broader digital twin adoption across medical device manufacturing while advancing Industry 4.0 capabilities in FDA-regulated environments.